Farnesyltransferase inhibition overcomes the adaptive resistance to targeted therapies in oncogene-addicted non-small cell lung cancer
Ontology highlight
ABSTRACT: Farnesyltransferase inhibition overcomes the adaptive resistance to targeted therapies in oncogene-addicted non-small cell lung cancer
PROVIDER: PRJNA1044045 | ENA |
REPOSITORIES: ENA
ACCESS DATA